Acadia Healthcare Company, Inc.
We are in a very active period for institutional investors, because it has been several weeks since the end of March, and investors are required to file their Q1 13Fs with the Securities and Exchange Commission (SEC) within the following 45-day period. These filings are important because by analyzing them, one can see the recent moves made by a fund manager, the latest acquisitions, or sales of stakes. Let's more »
Celgene Corporation (NASDAQ: CELG), a multinational biopharmaceutical company based in Summit, New Jersey, primarily produces drug treatments for cancer and inflammatory diseases, and takes part in the detection, advancement, and commercialization of therapies intended to provide a breakthrough in the field of medicine. Since its establishment in 1986, the company has been investing in research and progress, as well as providing products such as Thalomid (thalidomide), Revlimid (lenalidomide), Vidaza (azacitidine more »
Warren Buffett’s Berkshire Hathaway has continued buying shares of DaVita (NYSE: DVA) in the month of October, including a purchase of over 60,000 shares on October 16. Berkshire had initiated its position in the company in the fourth quarter of 2011, with 2.7 million shares in its portfolio at the end of the year, and then increased its stake further in the first half of the year more »